jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Fungal Stain (KOH Mount)

Bacterial/ Viral
image

Report in 12Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

KOH mount (Potassium Hydroxide Mount) is a simple, rapid microscopic test used to detect fungal elements like hyphae, spores, or yeast cells

99150

34% OFF

Fungal Stain (KOH Mount) - Comprehensive Medical Test Guide

  • Section 1: Why is it done?
    • Test Overview: The KOH (Potassium Hydroxide) mount is a microscopic examination technique used to detect and identify fungal elements in clinical specimens. The specimen is treated with potassium hydroxide solution, which dissolves cellular components and bacterial material while preserving fungal structures, making them more visible under the microscope.
    • Primary Indications: Suspected fungal infections of the skin, nails, hair, or mucous membranes; evaluation of vaginal discharge for Candida species; investigation of tinea infections; assessment of scalp or hair conditions; diagnosis of pityriasis versicolor; evaluation of suspected oral thrush or other oropharyngeal fungal infections.
    • Specimen Collection Timing: Test is performed immediately when fungal infection is clinically suspected; no special timing required; specimens should be processed as soon as possible after collection to prevent deterioration; can be performed in outpatient settings, emergency departments, or clinical laboratories.
    • Clinical Circumstances: When patients present with pruritic rashes, discolored nails, scaling skin lesions, vaginal itching and discharge, oral white patches, or other signs suggestive of fungal involvement; particularly useful as a rapid, preliminary screening test before sending samples for fungal culture.
  • Section 2: Normal Range
    • Normal Result Interpretation: NEGATIVE - No fungal elements observed on microscopic examination; this is the normal or expected result; indicates absence of detectable fungi in the specimen.
    • Reference Values: 0 fungal organisms per microscopic field; no yeast cells identified; no hyphae or pseudohyphae present; no spores visualized; normal epithelial cells and other cellular material visible.
    • Units of Measurement: Qualitative/morphological identification (reported as presence or absence; organisms described by characteristic appearance); typically reported as: Negative/Not seen, 1+ (few), 2+ (moderate), or 3+ (numerous); may include descriptive terminology such as 'budding yeast cells,' 'hyphae,' or 'pseudohyphae.'
    • Interpretation of Results: Negative = No fungal infection detected in specimen; Positive = Fungal elements identified, consistent with fungal infection; 1+ = Minimal fungal growth, may be contamination or early infection; 2+ = Moderate fungal elements, suggestive of active infection; 3+ = Numerous fungal organisms, consistent with significant fungal infection.
    • Clinical Significance: Normal (negative) result suggests no fungal infection present; however, negative KOH does not completely exclude fungal infection (approximately 20-30% false-negative rate); clinical correlation and confirmatory testing may be needed.
  • Section 3: Interpretation
    • Positive Result Interpretation: Indicates presence of fungal elements in the specimen; highly suggestive of fungal infection; requires clinical correlation with patient symptoms and signs; organism morphology may provide preliminary identification of fungal type.
    • Fungal Morphologies Observed: Budding yeast cells (round or oval, single or multiple daughter cells) = Candida species; Hyphae and pseudohyphae = Dermatophytes or other filamentous fungi; Spores = Various fungal types; Branching hyphae with septa = Often Aspergillus or other environmental fungi; Thick-walled cells with 'spaghetti and meatballs' appearance = Malassezia furfur (pityriasis versicolor).
    • Factors Affecting Results: Specimen quality and collection technique; timing of specimen processing; KOH concentration and preparation; microscope magnification and quality; examiner experience and skill; specimen contamination; prior antifungal therapy; stage of fungal infection; adequacy of specimen obtained.
    • Negative Result Considerations: Does not definitively exclude fungal infection (sensitivity ranges 40-80% depending on specimen type); may occur with inadequate specimen collection, early infection, sparse organism load, or deep dermatophyte infections; clinical suspicion should prompt additional testing such as fungal culture or dermoscopy.
    • Clinical Significance Patterns: Positive KOH with compatible clinical presentation = Strong evidence of fungal infection; Positive KOH with atypical presentation = May indicate colonization or contamination; High organism load (3+) = Suggestive of active, clinically significant infection; Low organism load (1+) = May represent early infection, contamination, or colonization; Specific morphology = May predict likely organism type and guide treatment decisions.
  • Section 4: Associated Organs
    • Primary Organ Systems Involved: Integumentary system (skin, hair, nails); Mucous membranes (oral cavity, genitalia); Reproductive system (vaginal/urogenital tract); Gastrointestinal tract (esophageal candidiasis); Respiratory tract (oral/pharyngeal involvement).
    • Common Fungal Infections Diagnosed: Candidiasis (oral thrush, vulvovaginal candidiasis, esophageal candidiasis); Dermatophytoses (tinea pedis, tinea corporis, tinea cruris, tinea capitis, tinea unguium/onychomycosis); Pityriasis versicolor; Tinea versicolor; Aspergillosis (cutaneous involvement); Malassezia infections; Cryptococcosis.
    • Associated Medical Conditions: Immunosuppression (HIV/AIDS, chemotherapy, transplantation); Diabetes mellitus; Antibiotic use (disrupting normal flora); Corticosteroid use; Oral contraceptives; Pregnancy; Poor hygiene; Warm, moist environments; Athletic participation; Direct contact with infected individuals.
    • Potential Complications: Dissemination to internal organs in immunocompromised patients; Secondary bacterial superinfection; Chronic recurrent infections; Nail dystrophy with permanent changes; Significant pruritus affecting quality of life; Allergic sensitization to fungal antigens; Systemic complications if untreated (particularly with invasive fungal species).
    • Risk Factors for Abnormal Results: Compromised immune function; Prolonged hospitalization; Recent antibiotic therapy; Poor hygiene practices; Environmental exposure (public showers, pools); Crowded living conditions; Occupational exposure; Genetic predisposition to fungal infections.
  • Section 5: Follow-up Tests
    • Confirmatory Testing if Positive: Fungal culture on appropriate media (Sabouraud dextrose agar, yeast extract peptone dextrose); Gram stain if bacterial involvement suspected; Periodic acid-Schiff (PAS) staining for enhanced fungal visualization; Gomori methenamine silver stain for selected organisms; Wood's lamp examination (particularly for pityriasis versicolor and tinea capitis).
    • Further Investigations When Negative: Fungal culture (gold standard for identification); Dermoscopy examination; Repeat KOH preparation with multiple specimens; Bacterial culture if secondary bacterial infection suspected; Skin biopsy with histological examination if diagnosis remains unclear; Specialized stains (PAS, GMS) on biopsy material.
    • Species Identification and Susceptibility: Culture followed by MALDI-TOF mass spectrometry for rapid species identification; Fungal susceptibility testing (particularly for Candida species and azole resistance); DNA testing or PCR for specific organisms if available.
    • Monitoring Frequency for Ongoing Conditions: Acute infections: Follow-up testing 2-4 weeks after treatment initiation; Recurrent infections: Periodic testing (monthly to quarterly) depending on frequency; Chronic onychomycosis: Testing at treatment conclusion and 6-12 months post-treatment; Immunocompromised patients: More frequent monitoring as clinically indicated; Oral candidiasis in HIV: Periodic assessment during immune reconstitution therapy.
    • Complementary Diagnostic Tests: Complete blood count (if systemic infection suspected); Blood cultures if invasive candidiasis suspected; CD4 count in HIV patients; Serum antigen testing (for Cryptococcus, Histoplasma); Imaging studies (chest X-ray for pulmonary involvement); Endoscopy if esophageal candidiasis suspected.
  • Section 6: Fasting Required?
    • Fasting Requirement: NO - Fasting is NOT required for this test. The KOH mount is a direct microscopic examination of clinical specimens (skin scrapings, nail clippings, hair, swabs, or exudates) and does not involve blood drawing or systemic absorption of medications.
    • Pre-Test Patient Preparation: Do NOT wash or cleanse the affected area immediately before specimen collection; avoid applying topical medications, lotions, or powders 24 hours before collection; do not use nail polish before collecting nail specimens; for skin scrapings, allow area to air dry naturally before collection; maintain normal hygiene otherwise; patients may eat and drink normally; no dietary restrictions.
    • Medication Considerations: Do NOT apply topical antifungal medications for 2 weeks before specimen collection if possible; systemic antifungal medications should be held at physician's discretion; continue oral medications as prescribed unless specifically instructed otherwise; oral contraceptives and systemic medications do not affect test results; antibiotic use does not affect test validity but may impact fungal culture results.
    • Specimen Collection Instructions: Skin: Use sterile scalpel to scrape leading edge of lesion; collect scale and debris; Nails: Clip affected nail or scrape nail bed with scalpel; Hair: Pluck (do not cut) 10-15 hairs with follicles from affected scalp area; Vaginal: Use sterile cotton swab to collect discharge from posterior fornix; Oral: Use sterile swab to collect white plaques or erythematous areas; Specimens must be placed in sterile containers and labeled appropriately; deliver to laboratory promptly.
    • Special Considerations: Pregnancy does not contraindicate test; immunocompromised patients require no special preparation; children can undergo testing without modification; no fasting, sedation, or anesthesia required; test is non-invasive and safe for all patient populations; specimens obtained during clinical examination without need for additional office visits.

How our test process works!

customers
customers